Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

William Steele

Neurological Surgery Miami, FL Medical Doctor

NPI 1558700492 CMS profile 8388550

1321 Nw 14Th St, Ste 1200, Miami, FL 33125

Open in the dashboard

General payments

$23,965

185 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Steele of Miami, FL is reported in the CMS Open Payments database as having received $23,965 across 185 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,115 32
2024 General $10,172 26
2023 General $3,487 47
2022 General $2,216 33
2021 General $2,817 33
2020 General $1,159 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Steele
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to William Steele were reported at $4,115. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year William Steele Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $1,159 $294 $76–$2,174 $114
2021 $2,817 $387 $105–$2,432 $132
2022 $2,216 $542 $139–$2,989 $149
2023 $3,487 $534 $145–$2,697 $160
2024 $10,172 $574 $155–$3,046 $164
2025 $4,115 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Sanara MedTech Inc. $7,981 6 payments
  2. Medtronic, Inc. $6,494 86 payments
  3. Stryker Corporation $2,547 31 payments
  4. Alphatec Spine, Inc $1,889 12 payments
  5. Providence Medical Technology, Inc. $930 6 payments
  6. SI-BONE, Inc. $618 8 payments
  7. Medinc of Texas $495 1 payment
  8. NuVasive, Inc. $447 4 payments
  9. Biocomposites Inc $323 2 payments
  10. Nevro Corp. $320 5 payments
  11. Other $1,921 24 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $10,976 163 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,160 2 payments
  3. Travel and Lodging $4,829 18 payments
  4. Consulting Fee $1,000 2 payments
Products named General payments · program years 2020–2025
  1. CellerateRx $7,981 6 payments
  2. MAZOR X SYSTEM $3,935 55 payments
  3. CD HORIZON SPINAL SYSTEM $1,793 13 payments
  4. Other - Miscellaneous $960 4 payments
  5. SERRATO $413 8 payments
  6. ARIA $401 4 payments
  7. ES2 SPINAL SYSTEM $321 3 payments
  8. CAPRI CORPECTOMY CAGE SYSTEM $283 3 payments
  9. INTELLIS ADAPTIVESTIM $251 3 payments
  10. AVIATOR $239 3 payments
  11. Other $4,474 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

542

Median for Neurosurgery: 83

Drug cost

$5,919

Median for Neurosurgery: $872

Branded share of claims

23.4%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 77 $1,525
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 76 $1,341
Methylprednisolone Generic 170 $1,145
Gabapentin Generic 101 $654
Acetaminophen-Codeine Acetaminophen With Codeine Brand 51 $537
Dexamethasone Generic 21 $443
Tizanidine Hcl Generic 17 $115
Tramadol Hcl Generic 18 $103
Pregabalin Generic 11 $55

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$227,429

Medicare's payments for the services billed

Medicare patients

216

Average age 73

Services billed

690

117 women, 99 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 42%
Diabetes 34%
Osteoporosis 32%
Depression 29%
Chronic kidney disease 21%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record